Article
China-made mRNA Covid vaccine targeting Omicron starts trial production
Rating:
0.0
Views:
60
Likes:
1
Library:
1
CanSino Biologics' CS-2034 booster vaccine targets new Omicron variants driving a Covid-19 wave across China following the lifting of most pandemic curbs.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value